NCT05942703

Brief Summary

Obesity is recognized as a major public health problem. Recent research suggests the involvement of the gut microbiota in the development of obesity. Indeed, obese people are characterized by a dysbiotic intestinal microbiota. Periodontitis are chronic inflammatory oral pathologies linked to an imbalance between the bacterial etiological factor, oral dysbiosis, and the host's immune defenses.They lead to the destruction of the supporting tissues of the tooth and an apical migration of the periodontal attachment system, thus leading to the formation of the pathognomonic entity of the disease, the periodontal pocket.the presence of bacteria of oral origin such as Porphyromonas gingivalis (Pg) has been demonstrated in the adipose tissue of obese patients inducing a chronic low-grade inflammatory response by macrophages which leads to the proliferation of adipocyte precursors predisposing to obesity. The main objective is to assess the average amount of Porphyromonas gingivalis (Pg) in the saliva of obese people (BMI ≥ 30) with periodontitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
311

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

December 5, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 27, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

July 12, 2023

Status Verified

July 1, 2023

Enrollment Period

1.3 years

First QC Date

December 5, 2022

Last Update Submit

July 5, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Analysis by bacterial culture and taxonomic analysis (MiSEQ) of the microbiological composition of saliva

    Assess the microbiological composition of saliva and periodontal plaque in obese (BMI≥30) and non-obese (BMI\<30) patients with periodontitis.

    8 weeks

  • Analysis by bacterial culture and taxonomic analysis (MiSEQ) of the microbiological composition periodontal plaque

    Assess the microbiological composition of periodontal plaque in obese (BMI≥30) and non-obese (BMI\<30) patients with periodontitis.

    8 weeks

Study Arms (2)

obese patients

Patients with a body mass index superior or equal at 30 and with a periodontitis

Other: saliva samples

non-obese (BMI<30) patients

Patients with a body mass index inferior at 30 with a periodontitis

Other: saliva samples

Interventions

Saliva samples, which are part of the usual treatment, will be carried out before and after the non-surgical periodontal treatment

Also known as: periodontal plaque samples
non-obese (BMI<30) patientsobese patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

any patient coming for consultation in the periodontology department

You may qualify if:

  • over 18 years old
  • having periodontitis
  • able to receive information on the course of the study and to understand the information form to participate in the study.
  • having given their non-objection to participate in the study

You may not qualify if:

  • During pregnancy or breastfeeding
  • At risk of infection (existence of one or more known chronic infectious diseases)
  • Suffering from a general pathology contraindicating the performance of diagnostic procedures such as periodontal probing (patients at high risk of infective endocarditis according to the French National Agency for the Safety of Medicines and Products of Health ANSM)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UHToulouse

Toulouse, 31059, France

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sara LAURENCIN, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sara LAURENCIN, MD

CONTACT

Cathy NABET, Pr

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2022

First Posted

July 12, 2023

Study Start

December 5, 2022

Primary Completion

March 27, 2024

Study Completion

December 30, 2024

Last Updated

July 12, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations